NCT02767869View on ClinicalTrials.gov

Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions
Metabolic Syndrome X
Interventions
DRUG

Banaba

Banaba capsules of 500 mg two times per day before meals with a total dosis of 1000 mg per day.

DRUG

placebo

Calcined magnesia capsule, 500 mg, two times per day before meals with a total dose per day of 1000 mg

Trial Locations (1)

45037

Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT02767869 - Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity | Biotech Hunter | Biotech Hunter